Thrombus Detection on Central Venous Catheters in the Neonatal Intensive Care Unit
- 1 June 1994
- journal article
- research article
- Published by SAGE Publications in Angiology
- Vol. 45 (6) , 477-480
- https://doi.org/10.1177/000331979404500610
Abstract
Each step of an inflammatory reaction is triggered by one or several chemical or biological mediators such as arachidonic acid derivatives (prostaglandins [PG], leukotrienes [LT], or thromboxanes [TX]), vasoactive amines (histamine or serotonin), and oxygen free radicals (superoxide ion, 02-, or hydrogen peroxide, H202). In perivenous inflammation, these mediators play a prominent role in favoring vasodilatation (histamine), increasing membrane permeability (PGE2, histamine, free radicals) and providing a chemotactic signal for specialized cells, ie, neutrophil polynuclears, macrophages, lymphocytes (LTB4, free radicals). The antiinflammatory effects of Daflon 500 mg,* a micronized purified flavonoid fraction (90% diosmin, 10% hesperidin), were studied in different in vivo and in vitro models. In a model of inflammatory granuloma in the rat, Daflon 500 mg (100 mg/kg, orally) reduced edema formation and inhibited the synthesis for PGE2 (78.5%), PGF2α (45.2%) and TXB2 (59.5%) (Damon et al, Arzneim-Forsch/Drug Res 37:1149-1153, 1987). Intravenous injection of Daflon 500 mg (25 and 50 mg/kg) reduced the hyperglycemia induced by injection of alloxan in rat. This effect of Daflon 500 mg was linked to its ability to scavenge active oxygen radicals, demonstrated in vitro using human neutrophils (Lonchampt et al, Arzneim-forsch/Drug Res 39:882-885, 1989) or mouse peritoneal macrophages (Bodinier et al, manuscript in preparation) stimulated by zymosan. The free radical scavenger effect of Daflon 500 mg is observed at concentrations ranging from 10-7M to 10-4M, with half-maximal effect between 10-6M and 10-5M. Thus, Daflon 500 mg behaves as a potent protective agent against inflammatory disorders. These properties, demonstrated both in vivo and in vitro, justify itsKeywords
This publication has 27 references indexed in Scilit:
- Intracardiac thrombus formation with rapidly progressive heart failure in the neonate: treatment with tissue type plasminogen activator.Archives of Disease in Childhood, 1992
- Tissue plasminogen activator for the treatment of thromboembolism in infants and childrenThe Journal of Pediatrics, 1991
- Neonatal Thrombosis and the Thrombolytic SystemJournal of Pediatric Hematology/Oncology, 1988
- Reactive oxygen production, arachidonate metabolism and cyclic AMP in macrophagesBiochemical and Biophysical Research Communications, 1983
- Effect of quercetin on human polymorphonuclear leukocyte lysosomal enzyme release and phospholipid metabolismLife Sciences, 1982
- Selective inhibition of platelet lipoxygenase by baicaleinBiochemical and Biophysical Research Communications, 1982
- Urokinase therapy for a catheter-related right atrial thrombusThe Journal of Pediatrics, 1982
- Reactive oxygen production associated with arachidonic acid metabolism by peritoneal macrophagesBiochemical and Biophysical Research Communications, 1980
- Oxygen-Dependent Microbial Killing by PhagocytesNew England Journal of Medicine, 1978
- Chemiluminescence associated with phagocytosis of foreign particles in rabbit alveolar macrophagesLife Sciences, 1977